150
Participants
Start Date
February 1, 2023
Primary Completion Date
February 1, 2026
Study Completion Date
February 1, 2026
Genome sequencing
"100 extensively phenotyped pediatric and young adult patients for genotyping, metabolomic and lipidomic analyses. Polygenic risk scores for type 1 diabetes and cardiovascular disease will be performed.~For patients older than 6 years who agree to do a second visit (optional), a Mixed Meal Tolerance Test (MMTT: the gold standard for assessing beta cell function) will be done as well as transcriptomic analysis."
RECRUITING
University Hospital of Geneva, Geneva
Lead Sponsor
University Hospital, Geneva
OTHER
University of Geneva, Switzerland
OTHER
Pediatric Clinical Research Platform
OTHER